Clinical trial
Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of…
NCT00053209 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00053209 |
|---|---|
| Title | Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium |
| Official title | Phase II Trial Of Pemetrexed Disodium And Gemcitabine In Advanced Urothelial Cancer |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer |
| Intervention type | Drug |
| Interventions | gemcitabine hydrochloride, pemetrexed disodium |
| Enrollment | 46 |
| Start date | Aug 10, 2004 |
| Primary completion | Sep 1, 2007 |
| Completion | May 1, 2009 |
| First posted | Jan 28, 2003 |
| Last update posted | Jun 22, 2023 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: